Detalhe da pesquisa
1.
Phase 1 TRANSCEND CLL 004 study of lisocabtagene maraleucel in patients with relapsed/refractory CLL or SLL.
Blood
; 139(12): 1794-1806, 2022 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34699592
2.
Phase 2 study of epigenetic priming with decitabine followed by cytarabine for acute myeloid leukemia in older patients.
Am J Hematol
; 99(3): 380-386, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38258329
3.
A prospective study of the use of central venous catheters in patients newly diagnosed with acute myeloid leukemia treated with induction chemotherapy.
Support Care Cancer
; 30(2): 1673-1679, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34562168
4.
Outcomes of patients with large B-cell lymphoma progressing after axicabtagene ciloleucel therapy.
Blood
; 137(13): 1832-1835, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33156925
5.
Phase 1 clinical trial of adoptive immunotherapy using "off-the-shelf" activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia.
Cytotherapy
; 19(10): 1225-1232, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28864289
6.
Outcomes of patients diagnosed with acute myeloid leukemia after solid organ transplantation.
Clin Transplant
; 31(9)2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28710776
7.
Leukapheresis in patients newly diagnosed with acute myeloid leukemia.
Transfus Apher Sci
; 55(2): 216-220, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27470709
8.
Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium.
J Clin Oncol
; 41(14): 2594-2606, 2023 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36753699
9.
Rates and Predictors of Nonadherence to the Post-Allogeneic Hematopoietic Cell Transplantation Medical Regimen in Patients and Caregivers.
Transplant Cell Ther
; 28(3): 165.e1-165.e9, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34875403
10.
Co-clinical Modeling of the Activity of the BET Inhibitor Mivebresib (ABBV-075) in AML.
In Vivo
; 36(4): 1615-1627, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35738590
11.
Outcomes of Patients With Acute Myeloid Leukemia Who Relapse After 5 Years of Complete Remission.
Oncol Res
; 28(7): 811-814, 2021 Sep 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32753091
12.
Selective Inhibition of the Second Bromodomain of BET Family Proteins Results in Robust Antitumor Activity in Preclinical Models of Acute Myeloid Leukemia.
Mol Cancer Ther
; 20(10): 1809-1819, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34253595
13.
Primary Palliative Care for Patients with Advanced Hematologic Malignancies: A Pilot Trial of the SHARE Intervention.
J Palliat Med
; 2020 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33074775
14.
Prognostic significance of blast immunophenotype on first post-induction bone marrow biopsy.
Leuk Lymphoma
; 64(3): 750-752, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36722791
15.
A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML.
Leuk Lymphoma
; 63(13): 3257-3260, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36075047
16.
Mitoxantrone and Etoposide for the Treatment of Acute Myeloid Leukemia Patients in First Relapse.
Oncol Res
; 24(2): 73-80, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27296947
17.
STAT transcription factors in normal and cancer stem cells.
Adv Biol Regul
; 56: 30-44, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24931719
18.
Location matters in early stage nodal diffuse large B-cell lymphoma.
Leuk Lymphoma
; 60(1): 250-253, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29932787